From a cell to an algorithm.
We combine human biology with neural networks and build tools for medicine on that foundation.
The code that describes us.
Chronic obstructive pulmonary disease (COPD) is shaped by the environment, but also by genes. We described the biological and genetic mechanisms of the disease in a review published in Biomedicines (2023).
An impulse that moves the body.
A neuron sends an electrical signal along its axon. At the end of that path, a muscle is waiting.
Muscle signals turned into data.
Between 2017 and 2019 we developed a telerehabilitation platform. An armband with EMG sensors measures the electrical activity of muscles, and a system based on neural networks checks whether exercises at home are done correctly.
Co-financed by the European Union — Regional Operational Programme Lubuskie 2020
Billions of neurons, one principle.
The brain learns by strengthening the connections that often carry a signal. Artificial neural networks borrow that idea: they learn by tuning the strength of their connections.
A model that sees patterns.
A neural network learns to recognise patterns in medical data: in a recording of muscle activity or in an image from a phone camera.
COPD diagnostics from saliva.
We are developing saliva-based diagnostics for chronic obstructive pulmonary disease. We published the results of our research on salivary biomarkers in Biomedicines (2024).
Co-financed by the European Union — Smart Growth Operational Programme 2014–2020
Biology. Neural networks. Medicine.
Science you can check.
Evaluation of Salivary Biomarkers and Spirometry for Diagnosing COPD in Non-Smokers and Smokers of Polish Origin
doi.org/10.3390/biomedicines12061206 (opens in a new tab)Projects co-financed by the European Union
Development of an innovative rehabilitation platform by Recumed Sp. z o.o. through research and development work
- Programme
- Regional Operational Programme – Lubuskie 2020, Measure 1.1 Research and innovation
- Implementation period
- 20 March 2017 – 19 March 2019
- Project value
- PLN 4,884,452.93
- EU co-financing
- PLN 3,507,872.14
Space for the programme logo sets (files from Recumed)
Development of a new test set for rapid diagnostics of chronic obstructive pulmonary disease based on CRP, PCT, NE and AAT measured in saliva
- Programme
- Smart Growth Operational Programme 2014–2020, Sub-measure 1.1.1
- Implementation period
- 1 May 2021 – 31 December 2023
- Project value
- PLN 6,042,328.16
- EU co-financing
- PLN 4,262,303.12
Let’s talk.
Investing in medtech or interested in our projects? Write to us.
Prefer plain email? biuro@recumed.pl